The effect of grapefruit intake on endogenous serum estrogen levels in postmenopausal women

Nutrition and Cancer

Volumn 65, Issue 5, 2013, Pages 644-652

  Monroe, Kristine R ^a   Stanczyk, Frank Z ^a   Besinque, Kathleen H ^b   Pike, Malcolm C ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTRONE; ESTRONE SULFATE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; SODIUM CARBONATE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER RISK; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; FOOD INTAKE; FRUIT JUICE; GRAPEFRUIT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POSTMENOPAUSE;

AGED; BEVERAGES; BODY MASS INDEX; BODY WEIGHT; BREAST NEOPLASMS; CITRUS PARADISI; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; ESTROGENS; ESTRONE; FEMALE; HUMANS; INTERVENTION STUDIES; MIDDLE AGED; PILOT PROJECTS; POSTMENOPAUSE; QUESTIONNAIRES; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN;

EID: 84880439743     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.795982     Document Type: Article

References (36)

1. Bailey DG and Dresser GK: Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 4, 281-297, 2004.
2. Maskalyk J: Grapefruit juice: potential drug interactions. Can Med Assoc J 167, 279-280, 2002.
3. Dahan A and Altman H: Food-drug interaction: grapefruit juice augments drug bioavailability-mechanism, extent and relevance. Eur J Clin Nutr 58, 1-9, 2004.
4. Edgar B, Bailey D, Bergstrand R, Johnsson G, and Regardh CG. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine-and its potential clinical relevance. Eur J Clin Pharmacol 42, 313-317, 1992.
5. Lundahl J, Regardh CG, Edgar B, and Johnsson G: Effects of grapefruit juice ingestion-pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol 52, 139-145, 1997.
6. Lundahl JU, Regardh CG, Edgar B, and Johnsson G: The interaction effect of grapefruit juice is maximal after the first glass. Eur J Clin Pharmacol 54, 75-81, 1998.
7. Greenblatt DJ, von Moltke LL, Harmatz JS, Chen G, Weemhoff JL, et al.: Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice. Clin Pharmacol Ther 74, 121-129, 2003.
8. Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, et al.: Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther 68, 468-477, 2000.
9. Fukuda K, Guo L, Ohashi N, Yoshikawa M, and Yamazoe Y: Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction. J Chromatogr B Biomed Sci Appl 741, 195-203, 2000.
10. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, et al.: Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 99, 2545-2553, 1997.
11. Paine MF, Widmer WW, Hart HL, Pusek SN, Beavers KL, et al.: A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction. Am J Clin Nutr 83, 1097-1105, 2006.
12. Medical Letter: Drug interactions with grapefruit juice. Obstet Gynecol 105, 429-431, 2005.
13. Schubert W, Cullberg G, Edgar B, and Hedner T: Inhibition of 17 betaestradiol metabolism by grapefruit juice in ovariectomized women. Maturitas 20, 155-163, 1994.
14. Weber A, Jager R, Borner A, Klinger G, Vollanth R, et al.: Can grapefruit juice influence ethinylestradiol bioavailability? Contraception 53, 41-47, 1996.
15. Endogenous Hormones and Breast Cancer Collaborative Group: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94, 606-616, 2002.
16. Monroe KR, Murphy SP, Kolonel LN, and Pike MC: Prospective study of grapefruit intake and risk of breast cancer in postmenopausal women: the Multiethnic Cohort Study. Br J Cancer 97, 440-445, 2007.
17. Kim EH, Hankinson SE, Eliassen AH, andWillett WC: A prospective study of grapefruit and grapefruit juice intake and breast cancer risk. Br J Cancer 98, 240-241, 2008.
18. Spencer EA, Key TJ, Appleby PN, van Gils CH, Olsen A, et al.: Prospective study of the association between grapefruit intake and risk of breast cancer in the European Prospective Investigation into Cancer andNutrition (EPIC). Cancer Causes Control 20, 803-809, 2009.
19. Probst-Hensch NM, Ingles SA, Diep AT, Haile RW, Stanczyk FZ, et al.: Aromatase and breast cancer susceptibility. Endocr Relat Cancer 6, 165-173, 1999.
20. Slater CC, Hodis HN, Mack WJ, Shoupe D, Paulson RJ, et al.: Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women. Menopause 8, 200-203, 2001.
21. Monroe KR, Murphy SP, Henderson BE, Kolonel LN, Stanczyk FZ, et al.: Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: the multiethnic cohort study. Nutr Cancer 58, 127-135, 2007.
22. Hankinson SE,Manson JE, Spiegelman D,Willett WC, Longcope C, et al.: Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 4, 649-654, 1995.
23. Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, et al.: Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomarkers Prev 19, 492-502, 2010.
24. Pasqualini JR: The selective estrogen enzyme modulators in breast cancer: a review. Biochim Biophys Acta 1654, 123-143, 2004.
25. Suzuki T, Miki Y, Nakamura Y, Moriya T, Ito K, et al.: Sex steroidproducing enzymes in human breast cancer. Endocr Relat Cancer 12, 701-720, 2005.
26. Pasqualini JR and Chetrite GS: Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 93, 221-236, 2005.
27. Kulendran M, Salhab M, and Mokbel K: Oestrogen-synthesising enzymes and breast cancer. Anticancer Res 29, 1095-1109, 2009.
28. Pasqualini JR: Breast cancer and steroid metabolizing enzymes: the role of progestogens. Maturitas 65(Suppl 1), S17-S21, 2009.
29. Chetrite GS, Thomas JL, Shields-Botella J, Cortes-Prieto J, Philippe JC, et al.: Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues. Anticancer Res 25, 2827-2830, 2005.
30. Lonning PE,Haynes BP, Straume AH, Dunbier A, Helle H, et al.: Exploring breast cancer estrogen disposition: the basis for endocrine manipulation. Clin Cancer Res 17, 4948-4958, 2011.
31. Messer A, Nieborowski A, Strasser C, Lohr C, and Schrenk D: Major furocoumarins in grapefruit juice I: levels and urinary metabolite(s). Food Chem Toxicol 49, 3224-3231, 2011.
32. Wanwimolruk S and Marquez PV:Variations in content of active ingredients causing drug interactions in grapefruit juice products sold in California. Drug Metabol Drug Interact 21, 233-243, 2006.
33. Widmer W and Haun C: Variation in furanocoumarin content and new furanocoumarin dimers in commercial grapefruit (Citrus paradisi Macf.) juices. J Food Sci 70, C307-C312, 2005.
34. Hanley MJ, Cancalon P, Widmer WW, and Greenblatt DJ. The effect of grapefruit juice on drug disposition. Expert Opin Drug Metab Toxicol 7, 267-286, 2011.
35. Seden K, Dickinson L, Khoo S, and Back D. Grapefruit-drug interactions. Drugs 70, 2373-2407, 2010.
36. Tapaninen T, Neuvonen PJ, and Niemi M: Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate Aliskiren. Clin Pharmacol Ther 88, 339-342, 2010.